Product Description: Abciximab (C7E3), a chimeric mouse/human monoclonal antibody fragment, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors[1].
Applications: Neuroscience-Neuromodulation
Formula: N/A
References: [1]Ibbotson T, et al. Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation. Drugs. 2003;63(11):1121-63./[2]Wu CH, et al. Mechanisms involved in the inhibition of neointimal hyperplasia by abciximab in a rat model of balloon angioplasty. Thromb Res. 2001 Feb 1;101(3):127-38.
CAS Number: 143653-53-6
Molecular Weight: N/A
Compound Purity: 99.966
Research Area: Cardiovascular Disease
Solubility: H2O
Target: Integrin
English
Deutsch
